Header Logo

Connection

PHILIP NG to Adenoviridae

Back to Details
This is a "connection" page, showing publications PHILIP NG has written about Adenoviridae.
PHILIP NG
Connection Strength
3.674
Adenoviridae
  1. Transgene expression up to 7 years in nonhuman primates following hepatic transduction with helper-dependent adenoviral vectors. Hum Gene Ther. 2013 Aug; 24(8):761-5.
    View in: PubMed
    Score: 0.309
  2. Balloon catheter delivery of helper-dependent adenoviral vector results in sustained, therapeutic hFIX expression in rhesus macaques. Mol Ther. 2012 Oct; 20(10):1863-70.
    View in: PubMed
    Score: 0.288
  3. Correction of hyperbilirubinemia in gunn rats using clinically relevant low doses of helper-dependent adenoviral vectors. Hum Gene Ther. 2011 Apr; 22(4):483-8.
    View in: PubMed
    Score: 0.261
  4. Vasoactive intestinal peptide increases hepatic transduction and reduces innate immune response following administration of helper-dependent Ad. Mol Ther. 2010 Jul; 18(7):1339-45.
    View in: PubMed
    Score: 0.247
  5. Progress towards liver and lung-directed gene therapy with helper-dependent adenoviral vectors. Curr Gene Ther. 2009 Oct; 9(5):329-40.
    View in: PubMed
    Score: 0.237
  6. Methods for the production of helper-dependent adenoviral vectors. Methods Mol Biol. 2008; 433:33-53.
    View in: PubMed
    Score: 0.210
  7. Methods for the production of first generation adenoviral vectors. Methods Mol Biol. 2008; 433:55-78.
    View in: PubMed
    Score: 0.210
  8. Pseudo-hydrodynamic delivery of helper-dependent adenoviral vectors into non-human primates for liver-directed gene therapy. Mol Ther. 2007 Apr; 15(4):732-40.
    View in: PubMed
    Score: 0.197
  9. Progress towards the clinical application of helper-dependent adenoviral vectors for liver and lung gene therapy. Curr Opin Mol Ther. 2006 Oct; 8(5):446-54.
    View in: PubMed
    Score: 0.193
  10. Increased hepatic transduction with reduced systemic dissemination and proinflammatory cytokines following hydrodynamic injection of helper-dependent adenoviral vectors. Mol Ther. 2005 Jul; 12(1):99-106.
    View in: PubMed
    Score: 0.177
  11. Helper-dependent adenoviral vectors for gene therapy. Hum Gene Ther. 2005 Jan; 16(1):1-16.
    View in: PubMed
    Score: 0.171
  12. Physical and infectious titers of helper-dependent adenoviral vectors: a method of direct comparison to the adenovirus reference material. Mol Ther. 2004 Oct; 10(4):792-8.
    View in: PubMed
    Score: 0.168
  13. Acute toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman primates. Hum Gene Ther. 2004 Jan; 15(1):35-46.
    View in: PubMed
    Score: 0.159
  14. Improved system for helper-dependent adenoviral vector production. Mol Ther. 2003 Nov; 8(5):846-52.
    View in: PubMed
    Score: 0.157
  15. Cre levels limit packaging signal excision efficiency in the Cre/loxP helper-dependent adenoviral vector system. J Virol. 2002 May; 76(9):4181-9.
    View in: PubMed
    Score: 0.142
  16. Differential type I interferon-dependent transgene silencing of helper-dependent adenoviral vs. adeno-associated viral vectors in vivo. Mol Ther. 2013 Apr; 21(4):796-805.
    View in: PubMed
    Score: 0.075
  17. Capsid-modified adenoviral vectors for improved muscle-directed gene therapy. Hum Gene Ther. 2012 Oct; 23(10):1065-70.
    View in: PubMed
    Score: 0.072
  18. Liver-directed gene therapy with helper-dependent adenoviral vectors: current state of the art and future challenges. Curr Pharm Des. 2011; 17(24):2488-99.
    View in: PubMed
    Score: 0.065
  19. Helper-dependent adenovirus-mediated gene transfer into the adult mouse cochlea. Otol Neurotol. 2007 Dec; 28(8):1100-8.
    View in: PubMed
    Score: 0.052
  20. Dendritic cell function after gene transfer with adenovirus-calcium phosphate co-precipitates. Mol Ther. 2007 Feb; 15(2):386-92.
    View in: PubMed
    Score: 0.049
  21. Modulation of adenoviral transduction in vitro and in vivo by hyaluronan and its receptor CD44. Mol Ther. 2007 Mar; 15(3):566-70.
    View in: PubMed
    Score: 0.049
  22. Lifelong elimination of hyperbilirubinemia in the Gunn rat with a single injection of helper-dependent adenoviral vector. Proc Natl Acad Sci U S A. 2005 Mar 15; 102(11):3930-5.
    View in: PubMed
    Score: 0.043
  23. Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responses. Mol Ther. 2005 Jan; 11(1):66-79.
    View in: PubMed
    Score: 0.043
  24. Toxicity and adaptive immune response to intracellular transgenes delivered by helper-dependent vs. first generation adenoviral vectors. Mol Genet Metab. 2005 Mar; 84(3):278-88.
    View in: PubMed
    Score: 0.043
  25. Long-term correction of ornithine transcarbamylase deficiency by WPRE-mediated overexpression using a helper-dependent adenovirus. Mol Ther. 2004 Sep; 10(3):492-9.
    View in: PubMed
    Score: 0.042
  26. Functional prestin transduction of immature outer hair cells from normal and prestin-null mice. J Assoc Res Otolaryngol. 2008 Sep; 9(3):307-20.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.